Clinical Trial Update: Fecal Calprotectin Levels, Quality of Life, and Workability in Patients Suffering From Ulcerative Colitis Under Adalimumab Therapy - AdaProQuo

View source ↗

Summary

This trial evaluated fecal calprotectin levels, quality of life, and workability in patients with moderate-to-severe ulcerative colitis receiving adalimumab. Th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• ADALIMUMAB (ADALIMUMAB-AATY)

Snippet

Sponsor: AbbVie | Conditions: Moderate to Severe Ulcerative Colitis | Status: TERMINATED | Results posted: 2017-02-23